Regulating Private Equity in Clinical Care Delivery—Lessons From California and Oregon
JAMA Internal Medicine · 01.07.2026 · 186 (7) · 797
DOI: 10.1001/jamainternmed.2026.1209 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.07.2026. Verfasst von David T Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, Virginia Commonwealth University School of Medicine, Richmond. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint examines regulatory frameworks, limitations and exemptions, and policy implications of corporate practice of medicine doctrines.
Autor:innen und Institutionen
- Medical Scientist Training Program, Virginia Commonwealth University School of Medicine, Richmond.
- Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
- Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.
- Cornell Health Policy Center, Weill Cornell Medicine, New York, New York.
Zitieren
APA
Zhu, D. T., Gondi, S., & Braun, R. T. (2026). Regulating Private Equity in Clinical Care Delivery—Lessons From California and Oregon. JAMA Internal Medicine, 186(7), 797. https://doi.org/10.1001/jamainternmed.2026.1209
Vancouver
Zhu DT, Gondi S, Braun RT. Regulating Private Equity in Clinical Care Delivery—Lessons From California and Oregon. JAMA Internal Medicine. 2026;186(7):797. doi:10.1001/jamainternmed.2026.1209
BibTeX
@article{Zhu2026,
author = {Zhu, David T and Gondi, Suhas and Braun, Robert Tyler},
title = {Regulating Private Equity in Clinical Care Delivery—Lessons From California and Oregon},
journal = {JAMA Internal Medicine},
year = {2026},
volume = {186},
number = {7},
pages = {797},
doi = {10.1001/jamainternmed.2026.1209}
}
EUVIMED